-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Mineralys Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2022 to Q2 2025.
- Mineralys Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2025 was $3.47M, a 16.4% decline year-over-year.
- Mineralys Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2025 was $12.3M, a 17.2% decline year-over-year.
- Mineralys Therapeutics, Inc. annual Nonoperating Income (Expense) for 2024 was $14.6M, a 14.4% increase from 2023.
- Mineralys Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $12.8M, a 659% increase from 2022.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)